Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 5/20 | 0.60 |
| ▸ | MAPT | P10636 | 5/20 | 0.60 |
| ▸ | LMNA | P02545 | 6/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | PRKCA | P17252 | 1/20 | 0.53 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.53 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.53 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | GMNN | O75496 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.49 |
| ▸ | TP53 | P04637 | 3/20 | 0.49 |
| ▸ | TSHR | P16473 | 3/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.49 |
| ▸ | BLM | P54132 | 2/20 | 0.49 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9397924 | 1.00 | MAPK1 (0.60) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL9395408 | 1.00 | MAPK1 (0.60) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL9397931 | 1.00 | MAPK1 (0.60) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL9396360 | 1.00 | MAPK1 (0.60) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL9395675 | 1.00 | MAPK1 (0.60) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL9395566 | 1.00 | MAPK1 (0.60) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL9395567 | 1.00 | MAPK1 (0.60) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL9396338 | 1.00 | MAPK1 (0.60) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL9396332 | 1.00 | MAPK1 (0.60) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL9395730 | 1.00 | MAPK1 (0.60) | MAPK1MAPTLMNAALDH1A1PRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1987000174-A2 | 1-O-PHOSPHONO-SACCHARIDES, METHOD FOR THE PRODUCTION AND UTILIZATION THEREOF | SANDOZ-ERFINDUNGEN VERWALTUNGSGESELLSCHAFT M.B.H. (AT) | 1987-01-15 | — | — | WO | claimed |
| US-8618080-B2 | Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines | OM PHARMA (CH) | 2013-12-31 | — | — | US | disclosed |
| US-20130035479-A1 | FUNCTIONALIZED BETA 1,6 GLUCOSAMINE DISACCHARIDES AND PROCESS FOR THEIR PREPARATION | OM PHARMA (CH) | 2013-02-07 | — | — | US | disclosed |
| US-7915240-B2 | Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines | OM PHARMA (CH) | 2011-03-29 | — | — | US | disclosed |
| US-20100168054-A1 | Functionalized Beta 1,6 Glucosamine Disaccharides and Process for Their Preparation | OM PHARMA (CH) | 2010-07-01 | — | — | US | disclosed |
| EP-2106403-A2 | FUNCTIONALIZED BETA 1,6 GLUCOSAMINE DISACCHARIDES AND PROCESS FOR THEIR PREPARATION | OM Pharma (CH) | 2009-10-07 | — | — | EP | disclosed |
| WO-2008059035-A2 | FUNCTIONALIZED BETA 1,6 GLUCOSAMINE DISACCHARIDES AND PROCESS FOR THEIR PREPARATION | OM PHARMA (CH) | 2008-05-22 | — | — | WO | disclosed |
| US-7157092-B1 | Acyl pseudodipeptides, preparation method and pharmaceutical compositions containing same | OM PHARMA (CH) | 2007-01-02 | — | — | US | disclosed |
| US-20060148678-A1 | Novel acyl-dipeptide-like compounds, a method for preparing the same and pharmaceutical compositions containing such products | OM PHARMA | 2006-07-06 | — | — | US | disclosed |
| EP-0316934-B1 | MURAMYL PEPTIDE DERIVATIVES AND USE THEREOF | Hasegawa, Akira (JP) | 1993-08-18 | — | — | EP | disclosed |
| EP-0330715-B1 | DISACCHARIDE DERIVATIVES | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 1993-06-16 | — | — | EP | disclosed |
| US-4895835-A | IMMUNOMODULATORS | NISSHIN OIL MILLS, LTD. (JP) | 1990-01-23 | — | — | US | disclosed |
| EP-0316934-A2 | Muramyl peptide derivatives and use thereof | Hasegawa, Akira (JP) | 1989-05-24 | — | — | EP | disclosed |
| WO-1987000174-A3 | 1-O-PHOSPHONO-SACCHARIDES, METHOD FOR THE PRODUCTION AND UTILIZATION THEREOF | SANDOZ AG (AT) | 1987-10-22 | — | — | WO | disclosed |
| WO-1987000174-A2 | 1-O-PHOSPHONO-SACCHARIDES, METHOD FOR THE PRODUCTION AND UTILIZATION THEREOF | SANDOZ-ERFINDUNGEN VERWALTUNGSGESELLSCHAFT M.B.H. (AT) | 1987-01-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060148678-A1 | Novel acyl-dipeptide-like compounds, a method for preparing the same and pharmaceutical compositions containing such products | PTMS, DNPEP, QPCT | MAPK1 3826/4885MAPT 3176/4885LMNA 3556/4885 |
| US-20130035479-A1 | FUNCTIONALIZED BETA 1,6 GLUCOSAMINE DISACCHARIDES AND PROCESS FOR THEIR PREPARATION | FUT6, FUT5, B3GNT2 | MAPK1 321/4885MAPT 4267/4885LMNA 3039/4885 |
| US-20100168054-A1 | Functionalized Beta 1,6 Glucosamine Disaccharides and Process for Their Preparation | FUT6, FUT5, B3GNT2 | MAPK1 321/4885MAPT 4267/4885LMNA 3039/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.